Dr. Gaetano Morello reports

EMERALD HEALTH THERAPEUTICS JOINT VENTURE LAUNCHES CANNABIS-FREE ENDOCANNABINOID-SUPPORTING HEALTH SUPPLEMENT IN CANADA

Emerald Health Therapeutics Inc., through its joint venture Emerald Health Naturals (EHN), has introduced a cannabis-free herbal and botanical endocannabinoid-supporting health supplement product line in Canada. EHN's Endo products, which do not contain cannabis or its derivatives, aim to support the endocannabinoid system to help maintain equilibrium in the body and are already available in over 200 natural health food stores across Canada.

The Endo product line includes Endo Brain, Endo Sleep, Endo Calm, Endo Bliss, Endo Inflame and Endo Omega, and are intended to foster overall health and wellness and potentially enhance the body's response to conditions such as stress, anxiety, restless sleep, inflammation and pain. These products feature PhytoCann complex, a proprietary formulation consisting of non-psychoactive, plant-based bioactive compounds that support the body's endocannabinoid system. All products are manufactured according to strict pharmaceutical quality standards.

"Many people who experience stress, inflammation and trouble sleeping, among other conditions, may be seeking natural health alternatives to conventional medications. While many are intrigued with the anecdotal benefits of cannabis, often there is still reluctance to try cannabis-based products," said Dr. Gaetano Morello, naturopathic doctor, chief executive officer of Emerald Health Naturals. "The Endo product line was developed by leading naturopathic doctors who previously launched new products into the natural health market, and we are pleased to now introduce Canadian consumers and retailers to this new nutritional supplement as an alternative to existing drugs, supplements and cannabis."

"Apart from our strongly positioned presence in the cannabis space, the Endo product launch allows us to uniquely expand Emerald's business opportunities by accessing natural health product, pharmacy and grocery stores, channels unavailable to cannabis products, with our non-cannabis supplements," said Dr. Avtar Dhillon, president and executive chairman of Emerald. "We see non-cannabis endocannabinoid-supporting products as the creation of a distinct and significant new natural health product category. Furthermore, our proprietary active ingredient, Phytocann complex, offers the potential to be incorporated into an array of supplements, foods and beverages."

Eighty per cent of Canadians consume natural health products each year (1). Emerald aims to widely offer its Endo products in retail outlets and is targeting more than 1,000 natural health product stores, pharmacies and grocery stores in Canada by the end of 2019.

Emerald's joint venture partner, Emerald Health Bioceuticals (EHB), formulated and launched the award-winning Endo line in 2018. Several of the Endo products have since won industry awards, including Taste For Life's 2019 Essentials Supplement Award, which recognizes the most outstanding natural supplements in health and wellness in the United States. Over the last year, EHB has secured multiple distribution and sales channels for the Endo product line in the U.S., ranging from national grocery chains such as Whole Foods Market to the Amazon website and over 1,300 independent natural health product retailers.

In 2018, Emerald Health Therapeutics secured Canadian distribution rights for the Endo product line through Emerald Health Naturals, its 51:49 joint venture with EHB.

About the endocannabinoid system

The endocannabinoid system (ECS) is made up of a network of receptor sites (CB1 and CB2) on cell membranes, chemical activators (cannabinoids) that fit into those sites like keys in locks, and enzymes that either synthesize those activators or break them down. ECS receptors have been found on almost every organ in the human body, with the highest concentration in the brain and central nervous system. The ECS, as part of the body's innate balancing mechanism, has been shown to play a role in regulating appetite, energy, metabolism, fertility and immunity as well as sleep, mood, pain perception and memory.

About the Endo product line*

Emerald's proprietary PhytoCann complex is a herbal and botanical complex completely free of cannabis or its derivatives.

• Endo Brain -- naturally supports mental acuity and cognition;
• Endo Sleep -- naturally promotes restful and rejuvenating sleep;
• Endo Calm -- naturally addresses your body's response to stress and anxiety;
• Endo Bliss -- naturally supports a positive outlook and resistance to daily pressures;
• Endo Inflame -- naturally promotes your body's healthy response to pain and inflammation;
• Endo Omega -- provides nutritional co-factors in precise ratios required by the body to produce omega-based endocannabinoids, essential to the state of whole-body wellness, promoting cardiovascular health, cognitive function, eye health, vitality and balance known as homeostasis.

* The statements made herein have not been evaluated by Health Canada or the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

(1) Fraser Institute, April 26, 2017, Complementary and Alternative Medicine: Use and Public Attitudes 1997, 2006 and 2016.

About Emerald Health Therapeutics Inc.

Emerald Health Therapeutics is a Canadian licensed producer of cannabis. Its 50-per-cent-owned Pure Sunfarms joint venture in British Columbia is licensed and fully planted in the first of its two 1.1-million-square-foot greenhouses. The capacity of each greenhouse is estimated to exceed 75,000 kilograms of cannabis annually. Emerald's Verdelite operation in Quebec is completing the buildout of its 88,000-square-foot indoor cultivation facility and is scaling up production.

We seek Safe Harbor.